Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

28.98
Delayed Data
As of Aug 28
 +0.44 / +1.54%
Today’s Change
12.27
Today|||52-Week Range
38.10
+77.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

--

--
Revenue and IncomeNet Revenues2.8M31.1M----
 
 
 
Depreciation And Amortization404.0K674.0K----
 
 
 
 
Operating ExpensesGross Income----------
General Expenses38.3M95.0M----
 
 
 
Research And Development31.3M78.2M----
 
 
 
Total Operating Expenses38.7M95.7M----
 
 
 
 
Non-Operating ExpensesOperating Income-36.0M-64.5M----
 
 
 
Extraordinary Credit--2.0M----
 
 
Extraordinary Charge---21.2M----
 
 
Interest Expense On Debt5.3M3.8M----
 
 
 
Other Expenses-12.3M377.0K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.6M-87.2M----
 
 
 
Minority Interest0.00-44.0K----
 
 
Net Income-53.6M-87.1M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.6M8.2M----
 
 
 
Shares To Calculate EPS Diluted5.6M8.2M----
 
 
 
 
Earnings Per ShareEPS-$9.66-$10.64----
 
 
 
EPS Diluted-$9.66-$10.64----